← back to search

Anthony Nardone

UK Health Security Agency · GB
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include HIV/AIDS Research and Interventions, HIV, Drug Use, Sexual Risk, Reproductive tract infections research, and Adolescent Sexual and Reproductive Health.
h-index
30
citations
5,494
works
131
NIH funding
primary concept
email

Recent publications

Redlines and Greenspace: The Relationship between Historical Redlining and 2010 Greenspace across the United States
Environmental Health Perspectives 2021cited by 353position: firstdoi
Associations between historical residential redlining and current age-adjusted rates of emergency department visits due to asthma across eight cities in California: an ecological study
The Lancet Planetary Health 2020cited by 331position: firstdoi
Associations between historical redlining and birth outcomes from 2006 through 2015 in California
PLoS ONE 2020cited by 137position: firstdoi
Using behavioural insights to increase <scp>HIV</scp> self‐sampling kit returns: a randomized controlled text message trial to improve England's <scp>HIV</scp> self‐sampling service
HIV Medicine 2018cited by 20position: lastdoi
Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation
The Lancet Infectious Diseases 2017cited by 120position: middledoi
Economic evaluation of HIV pre-exposure prophylaxis among men-who-have-sex-with-men in England in 2016
Eurosurveillance 2017cited by 17position: middledoi
Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study
PLoS ONE 2017cited by 7position: middledoi
The health and well-being of men who have sex with men (MSM) in Britain: Evidence from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)
BMC Public Health 2016cited by 155position: middledoi
Men who have sex with men in Great Britain: comparing methods and estimates from probability and convenience sample surveys
Sexually Transmitted Infections 2016cited by 113position: middledoi
High risks of lung disease associated with early-life and moderate lifetime arsenic exposure in northern Chile
Toxicology and Applied Pharmacology 2016cited by 60position: middledoi
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial
The Lancet 2015cited by 1,888position: middledoi
HIV testing, risk perception, and behaviour in the British population
AIDS 2015cited by 93position: middledoi
O1 Is pre-exposure prophylaxis for hiv prevention cost-effective in men who have sex with men who engage in condomless sex in the uk?
Sexually Transmitted Infections 2015cited by 25position: middledoi
Cost and cost-effectiveness of an HIV pre-exposure prophylaxis (PrEP) programme for high-risk men who have sex with men in England: results of a static decision analytical model
The Lancet 2015cited by 13position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Monica Desai · University of Manchester5 papers (2015–2017)Nigel Field · Mortimer Market Centre4 papers (2015–2017) · 3 papers (2015–2017)Andrew Phillips · Wake Forest University3 papers (2015–2017)Pam Sonnenberg · London School of Hygiene & Tropical Medicine3 papers (2015–2016)Joan A. Casey · Washington State Department of Health3 papers (2020–2021)Sheena McCormack · MRC Clinical Trials Unit at UCL3 papers (2015–2017)Soazig Clifton · London School of Hygiene & Tropical Medicine3 papers (2015–2016)Rachel Morello‐Frosch · Faculty of Public Health3 papers (2020–2021)Alison Rodger · Royal Free London NHS Foundation Trust2 papers (2015–2017)O Nöel Gill · UK Health Security Agency2 papers (2015–2017) · 2 papers (2015–2017)Wendy Macdowall · London School of Hygiene & Tropical Medicine2 papers (2015–2016)Valentina Cambiano · University College London2 papers (2015–2017) · 2 papers (2016–2016)Clare Tanton · London School of Hygiene & Tropical Medicine2 papers (2015–2016) · 2 papers (2015–2017)Albert-Jan van Hoek · University of London2 papers (2015–2017)John R. Balmes · University of California, San Francisco2 papers (2016–2020)Kara E. Rudolph · Columbia University2 papers (2020–2021)